Sharemaestro Newsreel

Labcorp Holdings Inc. stock underperforms Friday when compared to competitors

Labcorp Holdings Inc. (LH) stock fell 2.01% on Friday, closing at $309.20, despite a positive trading session for the broader market with the S&P 500 and Dow Jones Industrial Average both rising. The company's shares ended 2.19% below its 52-week high of $316.11, which …

Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,580.00 at Jefferies Financial Group

Jefferies Financial Group has increased its price target for Mettler-Toledo International (NYSE:MTD) to $1,580.00 from $1,400.00, maintaining a "Buy" rating. This adjustment suggests an 11.64% potential upside from the stock's previous closing price. The company recently reported strong quarterly earnings of $11.46 per share, …

JPMorgan Adjusts Price Target on Mettler-Toledo International to $1,400 From $1,200

JPMorgan has increased its price target for Mettler-Toledo International (NYSE:MTD) to $1,400, up from the previous target of $1,200. The firm maintained its "Overweight" rating on the company's stock. This adjustment reflects a more optimistic outlook by JPMorgan on Mettler-Toledo International's future performance.

Mettler-Toledo Earnings: Consensus Beat Drives Second Consecutive Guidance Raise

Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?

Thermo Fisher Scientific (TMO) recently reported strong Q2 2026 results, with revenue up 10% and adjusted EPS up 13%, leading analysts to raise price targets. The company's product innovation and recovery in its Life Sciences Solutions and Analytical Instruments segments fueled optimism, despite the …

Goldman Sachs Raises Price Target on Mettler-Toledo International to $1,440 From $1,340, Maintains Neutral Rating

Goldman Sachs has increased its price target for Mettler-Toledo International (MTD) to $1,440 from $1,340, while reaffirming a Neutral rating on the stock. This adjustment reflects an updated outlook by the firm. The article also lists several other analyst target adjustments for Mettler-Toledo International.

GENEDX HOLDINGS DEADLINE MONDAY AUGUST 3rd: Bragar Eagel & Squire, P.C. Urges GeneDx Holdings Corp. Investors to Contact the Firm Regarding Lead Plaintiff Deadline

Bragar Eagel & Squire, P.C. has announced a class action lawsuit against GeneDx Holdings Corp. (NASDAQ:WGS) for alleged federal securities law violations. The lawsuit claims GeneDx made false and misleading statements about its business, leading to a significant drop in stock price after the …

Myriad Genetics Is Maintained at Hold by TD Cowen

TD Cowen has reiterated its "Hold" rating for Myriad Genetics. The investment bank has also maintained its price target for the company.

METTLER TOLEDO International Inc. 2026: Revenue $1.03B, EPS $11.55— 10-Q Summary

METTLER TOLEDO International Inc. reported strong second-quarter 2026 results with revenue of $1.03 billion and diluted EPS of $11.55, both increasing year-over-year. Net earnings rose to $232.9 million, driven by improved product and service mix and robust performance in Europe and Asia. The company …

Price to earnings forward of bioAffinity Technologies, Inc. – NASDAQ:BIAF

This article provides financial information for bioAffinity Technologies, Inc. (NASDAQ: BIAF) on TradingView. It specifically highlights the company's "Price to earnings forward" metric. The content emphasizes that the data is compiled by humans and sourced from ICE Data Services and FactSet.

Mettler-Toledo (NYSE: MTD) lifts Q2 profit with tariff refunds and growth

Profusa Announces Signing of Option Agreement for the

Profusa, Inc. has signed an Option Agreement to potentially acquire G3 Vision Labs, a commercial-stage diagnostics company with estimated 2025 net revenues of $111 million. The acquisition is contingent on several conditions, including Profusa securing at least $30 million in financing and obtaining stockholder …

CareDx: Q2 Earnings Snapshot

This article provides a Q2 earnings snapshot for CareDx. Unfortunately, the content of the article itself is missing, preventing a detailed summary of the financial performance or key highlights.

Labcorp (LH) Stock Looks Cheap On Cash Flow While Earnings Look Full

Labcorp (LH) stock shows mixed valuation signals; its Discounted Cash Flow (DCF) model suggests it's 44.1% undervalued, while its P/E ratio indicates it's overvalued compared to earnings-based fair ratios. The company's recent launch of the Marker by Labcorp Genetic Health Panel could drive future …

Illumina, Inc. Stock 12‑Month Price Target Raised to $193.61, Implies 6% Downside

Illumina, Inc.'s average 12-month price target has been increased to $193.61 from $175.72 by 18 analysts, with forecasts ranging from $95 to $230 per share. This new target suggests a 6% potential downside based on the July 30 closing price. The consensus rating for …

Guardant Health Leads the Way in Blood-Based Single Cancer Screening

Guardant Health is positioned as a leader in liquid biopsy, offering market-leading platforms in tumor genomic profiling, molecular residual disease (MRD) testing, and colorectal cancer screening. Despite promising markets with multi-billion dollar revenue potential, the company faces early-stage uncertainties regarding payer coverage and guideline …

Vanguard Portfolio Management (MTD) discloses 5.01% Mettler-Toledo ownership position

Vanguard Portfolio Management LLC has disclosed a 5.01% ownership stake in Mettler-Toledo International Inc., according to a recent SCHEDULE 13G SEC filing. This amounts to 1,012,777 shares as of June 30, 2026, encompassing holdings from various Vanguard funds and managed accounts. Vanguard has sole …

Opko Health, Inc. Revenue Breakdown – NASDAQ:OPK

Opko Health, Inc. (NASDAQ: OPK) generated $606.90 million in revenue last year, with its Diagnostics segment being the top performer at $370.27 million. The United States was the largest geographical contributor, accounting for $436.06 million of the revenue. These figures provide a breakdown of …

NKTX|Nkarta Inc|Price:2.090|Chg%:-0.060

This article provides a detailed stock analysis of Nkarta Inc (NKTX), highlighting its weak fundamentals, high growth potential, and fair valuation within the Biotechnology & Medical Research industry. It notes high institutional ownership and recent "Buy" ratings from analysts with a target price of …

Labcorp Q2 Earnings Call Highlights

Labcorp (LH) reported strong Q2 2026 results with a 5.8% revenue increase to $3.7 billion and a 14.9% rise in adjusted EPS to $4.99, leading the company to raise its full-year revenue and adjusted EPS guidance. Growth was driven by solid performance in its …

THERMO FISHER SCIENTIFIC INC. 2026: Revenue $11.99B, EPS $4.68— 10-Q Summary

Thermo Fisher Scientific reported strong second-quarter 2026 results, with revenue reaching $11.99 billion and diluted EPS of $4.68, both showing an increase over the prior year. The growth was attributed to robust demand in pharma/biotech, high-end instruments, and operational efficiency gains. The company saw …

Twist Bioscience earnings loom as profitability path under scrutiny

Twist Bioscience Corp. is preparing to report its fiscal third-quarter results, with analysts expecting a loss of 49 cents per share on revenue of $114.6 million, indicating sequential improvement and significant year-over-year growth. The company's stock has rallied 154% over the past year, driven …

ILLUMINA INC : BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $140 FROM $120

BofA Global Research has increased its price objective for Illumina Inc. (ILMN.O) shares. The new target price is set at $140, up from the previous $120. This adjustment indicates a more positive outlook from the research firm regarding Illumina's future stock performance.

Transcript : Mettler-Toledo International Inc., Q2 2026 Earnings Call, Jul 31, 2026

Earnings call transcript: Mettler-Toledo tops Q2 2026 EPS forecasts, lifts outlook

Mettler-Toledo International Inc. (MTD) reported strong second-quarter 2026 results, surpassing EPS forecasts and matching revenue expectations, driven by robust sales in China and emerging markets. The company raised its full-year 2026 sales and earnings guidance, with adjusted EPS now expected between $47.15 and $47.50, …

Have Medpace Holdings Insiders Been Selling Stock?

Recent insider transactions at Medpace Holdings, Inc. revealed that an insider sold US$4.5 million worth of shares, reducing their holding by 11%. Over the last year, the CEO also sold US$62 million worth of shares at a price close to the current share price. …

Fulgent Genetics (FLGT) Stock Price Slides As Losses Deepen Guidance Falls

Fulgent Genetics (FLGT) saw its stock price fall by approximately 18% after reporting a significant quarterly net loss of US$29.5 million and lowering its full-year guidance. The company's revenue increased slightly year-on-year, but profitability challenges persist, with widening losses and reduced non-GAAP gross margins. …

Truist Raises Price Target on Labcorp Holdings to $350 From $320, Keeps Buy Rating

Truist has increased its price target for Labcorp Holdings (LH) to $350 from $320, while maintaining a "Buy" rating on the stock. This adjustment reflects continued positive sentiment from analysts towards the healthcare company. The article also notes other recent analyst updates, including Rothschild …

[10-Q] MYRIAD GENETICS INC Quarterly Earnings Report

Myriad Genetics Inc. (MYGN) has filed its quarterly earnings report (Form 10-Q) for the period ended June 30, 2026. The company reported a net loss of $43.2 million for Q2 2026 and $77.3 million for the six months ended June 30, 2026. Revenue experienced …

Is Guardant Health Inc (GH) Overvalued After Q2 Earnings Miss? E

Guardant Health Inc (GH) reported a strong Q2 2026 revenue growth of 44% to $335.0 million, driven by oncology and a surging screening division, but net losses widened to $120.1 million due to increased operational expenses. Despite raising 2026 revenue guidance, GuruFocus deems the …

Personalis Inc expected to post a loss of 26 cents a share - Earnings Preview

Personalis Inc is projected to report a loss of 26 cents per share, according to this earnings preview. The article, sourced from Reuters, provides an outlook on the company's upcoming financial performance.

Insight Molecular Diagnostics Inc. Revenue Breakdown – NASDAQ:IMDX

Insight Molecular Diagnostics Inc. (IMDX) generated $4.05 million USD last year, primarily from its Diagnostic Tests segment. The United States was the largest contributor to this revenue, accounting for $4.03 million USD. This represents a significant increase from the previous year's figures of $1.88 …

Rothschild & Co Redburn Adjusts Price Target on Labcorp Holdings to $385 From $325, Maintains Buy Rating

Rothschild & Co Redburn has increased its price target for Labcorp Holdings (NYSE:LH) to $385 from $325, while maintaining a Buy rating on the stock. This adjustment reflects a positive outlook on the company's financial prospects and market position.

Quest Diagnostics Incorporated (DGX) jumps 8.2% as volume nearly doubles

The diagnostics stock’s weekly advance gained confirmation from heavier turnover and positive momentum readings.

Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary

Fulgent Genetics Inc (FLGT) has released its earnings summary for the quarter ended June 30. The report, provided by Refinitiv, gives an overview of the company's financial performance. Full access to the article is available through a TradingView subscription.

Adaptive Biotechnologies Corp (ADPT) Institutional Confidence

The article discusses the institutional confidence score for Adaptive Biotechnologies Corp (ADPT), which is currently 10.00, ranking it 1st in the Biotechnology & Medical Research industry. Institutional shareholding stands at 94.68%, with a slight quarter-over-quarter decrease. Andreas Halvorsen is highlighted as the largest institutional …